company background image
SRTS

Sensus Healthcare NasdaqCM:SRTS Stock Report

Last Price

US$8.02

Market Cap

US$133.8m

7D

5.2%

1Y

82.3%

Updated

26 Jun, 2022

Data

Company Financials +
SRTS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance3/6
Financial Health6/6
Dividends0/6

SRTS Stock Overview

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide.

Sensus Healthcare Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Sensus Healthcare
Historical stock prices
Current Share PriceUS$8.02
52 Week HighUS$11.96
52 Week LowUS$3.21
Beta0.50
1 Month Change-10.29%
3 Month Change-29.96%
1 Year Change82.27%
3 Year Change44.77%
5 Year Change99.50%
Change since IPO37.09%

Recent News & Updates

May 21

Sensus Healthcare: A Buy In Honor Of Skin Cancer Awareness Month

Sensus has developed an FDA-cleared laser device that targets non-melanoma skin cancers and keloids. While 2021 was a tough time for the company as elective procedures non-existent during the pandemic. However, a swift rebound occurred of late that has driven revenues and earnings to all-time highs. I believe this trend will continue thanks to advantageous tech platform, TAM, and operational excellence.

May 11
Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts

Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts

Sensus Healthcare, Inc. ( NASDAQ:SRTS ) shareholders will have a reason to smile today, with the analysts making...

Apr 29
Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist

Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...

Shareholder Returns

SRTSUS Medical EquipmentUS Market
7D5.2%7.0%6.6%
1Y82.3%-23.6%-18.4%

Return vs Industry: SRTS exceeded the US Medical Equipment industry which returned -23.7% over the past year.

Return vs Market: SRTS exceeded the US Market which returned -18.5% over the past year.

Price Volatility

Is SRTS's price volatile compared to industry and market?
SRTS volatility
SRTS Average Weekly Movement11.1%
Medical Equipment Industry Average Movement10.4%
Market Average Movement8.1%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.2%

Stable Share Price: SRTS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: SRTS's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
201037Joe Sardanohttps://www.sensushealthcare.com

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.

Sensus Healthcare Fundamentals Summary

How do Sensus Healthcare's earnings and revenue compare to its market cap?
SRTS fundamental statistics
Market CapUS$133.75m
Earnings (TTM)US$21.30m
Revenue (TTM)US$34.31m

6.3x

P/E Ratio

3.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SRTS income statement (TTM)
RevenueUS$34.31m
Cost of RevenueUS$11.76m
Gross ProfitUS$22.55m
Other ExpensesUS$1.26m
EarningsUS$21.30m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.28
Gross Margin65.73%
Net Profit Margin62.07%
Debt/Equity Ratio0%

How did SRTS perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is SRTS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SRTS?

Other financial metrics that can be useful for relative valuation.

SRTS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3x
Enterprise Value/EBITDA10.5x
PEG Ratio-0.1x

Price to Earnings Ratio vs Peers

How does SRTS's PE Ratio compare to its peers?

SRTS PE Ratio vs Peers
The above table shows the PE ratio for SRTS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average251x

Price-To-Earnings vs Peers: SRTS is good value based on its Price-To-Earnings Ratio (6.3x) compared to the peer average (251x).


Price to Earnings Ratio vs Industry

How does SRTS's PE Ratio compare vs other companies in the U.S. Medical Equipment Industry?

Price-To-Earnings vs Industry: SRTS is good value based on its Price-To-Earnings Ratio (6.3x) compared to the US Medical Equipment industry average (34.8x)


Price to Earnings Ratio vs Fair Ratio

What is SRTS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SRTS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio6.3x
Fair PE Ratio6.2x

Price-To-Earnings vs Fair Ratio: SRTS is expensive based on its Price-To-Earnings Ratio (6.3x) compared to the estimated Fair Price-To-Earnings Ratio (6.2x).


Share Price vs Fair Value

What is the Fair Price of SRTS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SRTS ($8.02) is trading above our estimate of fair value ($3.13)

Significantly Below Fair Value: SRTS is trading above our estimate of fair value.


Price to Earnings Growth Ratio

PEG Ratio: SRTS's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Discover undervalued companies

Future Growth

How is Sensus Healthcare forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-45.6%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SRTS's earnings are forecast to decline over the next 3 years (-45.6% per year).

Earnings vs Market: SRTS's earnings are forecast to decline over the next 3 years (-45.6% per year).

High Growth Earnings: SRTS's earnings are forecast to decline over the next 3 years.

Revenue vs Market: SRTS's revenue (9.1% per year) is forecast to grow faster than the US market (8.4% per year).

High Growth Revenue: SRTS's revenue (9.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SRTS's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Past Performance

How has Sensus Healthcare performed over the past 5 years?

Past Performance Score

3/6

Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


34.4%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: SRTS has a high level of non-cash earnings.

Growing Profit Margin: SRTS became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: SRTS has become profitable over the past 5 years, growing earnings by 34.4% per year.

Accelerating Growth: SRTS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: SRTS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.9%).


Return on Equity

High ROE: SRTS's Return on Equity (50.2%) is considered outstanding.


Discover strong past performing companies

Financial Health

How is Sensus Healthcare's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: SRTS's short term assets ($48.5M) exceed its short term liabilities ($10.3M).

Long Term Liabilities: SRTS's short term assets ($48.5M) exceed its long term liabilities ($1.2M).


Debt to Equity History and Analysis

Debt Level: SRTS is debt free.

Reducing Debt: SRTS has no debt compared to 5 years ago when its debt to equity ratio was 11%.

Debt Coverage: SRTS has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: SRTS has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Dividend

What is Sensus Healthcare current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate SRTS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SRTS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SRTS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SRTS's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as SRTS has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.4yrs

Average management tenure


CEO

Joe Sardano (68 yo)

12yrs

Tenure

US$630,451

Compensation

Mr. Joseph C. Sardano, also known as Joe, serves as Director at BioFlorida Inc since August 2021. He Co-Founded Sensus Healthcare, Inc. in 2010 and has been its Chairman of the Board, Chief Executive Offic...


CEO Compensation Analysis

Compensation vs Market: Joe's total compensation ($USD630.45K) is about average for companies of similar size in the US market ($USD752.25K).

Compensation vs Earnings: Joe's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: SRTS's management team is considered experienced (2.4 years average tenure).


Board Members

Experienced Board: SRTS's board of directors are considered experienced (9.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: SRTS insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sensus Healthcare, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Sensus Healthcare, Inc.
  • Ticker: SRTS
  • Exchange: NasdaqCM
  • Founded: 2010
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$133.754m
  • Shares outstanding: 16.68m
  • Website: https://www.sensushealthcare.com

Number of Employees


Location

  • Sensus Healthcare, Inc.
  • 851 Broken Sound Parkway NW
  • Suite 215
  • Boca Raton
  • Florida
  • 33487
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/26 00:00
End of Day Share Price2022/06/24 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.